Who owns PIP - PHARMATHENE INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

PHARMATHENE INC - COM (PIP) Institutional Ownership

Q: What is CUSIP 71714G102?

CUSIP 71714G102 is the security identifier used in SEC filing datasets for PIP - PHARMATHENE INC - COM.

CUSIP: 71714G102

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2017

Type / Class: Equity / COM
Symbol: PIP

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 71714G102?
CUSIP 71714G102 identifies PIP - PHARMATHENE INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 71714G102:

Q2 2017 (0 holders) Q1 2017 (65 holders) Q4 2016 (88 holders) Q3 2016 (62 holders) Q2 2016 (47 holders) Q1 2016 (35 holders) Q4 2015 (33 holders) Q3 2015 (30 holders) Q2 2015 (34 holders) Q1 2015 (33 holders)

Institutional Holders of PHARMATHENE INC - COM (PIP) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2017 Q2	0	$0	-$20,311,015	$0			0
2017 Q1	25,037,150	$20,311,017	-$24,578,825	$146,000	$0	$0.81	65
2016 Q4	27,725,997	$90,102,828	+$5,607,300	$0	$144,000	$3.25	88
2016 Q3	26,098,351	$75,684,665	+$2,361,820	$103,000	$0	$2.90	62
2016 Q2	25,283,374	$61,688,535	+$8,865,566	$51,000	$71,000	$2.44	47
2016 Q1	22,047,073	$41,917,000	-$10,734,498		$40,000	$1.89	35
2015 Q4	27,683,133	$52,598,000	-$386,471		$31,000	$1.90	33
2015 Q3	28,574,335	$38,001,000	+$1,040,093		$833,000	$1.33	30
2015 Q2	28,372,896	$51,073,540	+$4,111,680			$1.80	34
2015 Q1	26,095,911	$32,181,836	-$2,105,768		$0	$1.63	33
2014 Q4	27,019,164	$48,846,543	+$1,697,829		$3,000	$1.81	42
2014 Q3	26,045,001	$46,361,534	+$10,620,194	$0	$0	$1.78	36
2014 Q2	20,120,691	$28,372,723	+$276,011	$3,000	$25,000	$1.41	34
2014 Q1	19,835,616	$36,271,158	-$95,906		$266,000	$1.83	37